Allergy Immunotherapy Market to Surpass US$ 4,312.6 Million by 2030, Says Coherent Market Insights

News provided by

Feb 14, 2022, 13:00 ET

SEATTLE, Feb. 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global allergy immunotherapy market is estimated to be valued at US$ 2,116.0 million in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period (2022-2030).

Key Trends and Analysis of the Global Allergy Immunotherapy Market:

The increasing funding for research & development of novel treatment is propelling the growth of the market. Additionally, approvals of allergy drugs by various regulatory authorities and market consolidation is also boosting the market growth. For instance, in October 2017, Stallergenes Greer, a biopharmaceutical company was acquired by Medic Savoure Ltd. a testing laboratory to strengthen its global presence in the pollen allergy industry in Canada.

Increasing product approval by regulatory authority is expected to boost the market growth over the forecast period. For instance, in 2017, Merck & Co., Inc., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for MK-8237, Investigational House Dust Mite Sublingual Allergy Immunotherapy Tablet.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4915

Key Market Takeaways:

The global allergy immunotherapy market is expected to exhibit a CAGR of 9.3% over the forecast period, owing to rising prevalence of allergic reaction. For instance, according to the World Health Organization (WHO), around 10-30% of people globally have allergic rhinitis. Moreover, grass and tree pollen are among the most common allergy triggers.

Among region, North America is expected to exhibit a high growth rate in the global allergy immunotherapy market during the forecast period, owing to the increasing prevalence of food allergy. For instance, according to a report published by Food Allergy Research and Foundation, around 32 million people in the U.S. have food allergies, which occur one in 10 adult and one in 13 children, moreover each year in the U.S. around 200,000 people require emergency medical care for allergic reaction to food.

Key players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier .

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/4915

Detailed Segmentation:

Global Allergy Immunotherapy Market, By Treatment Type:

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

Global Allergy Immunotherapy Market, By Allergy Type:

Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others

Global Allergy Immunotherapy Market, By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Global Allergy Immunotherapy Market, By Region:

North America

By Country:

U.S.
Canada

Europe

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Middle East & Africa

By Country:

GCC Countries
Israel
South Africa
Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/4915

Find more related trending reports below:

Allergy Treatment Drugs Market, by Allergy Type (Drug Allergy, Eye Allergy, Food Allergy, Skin Allergy, Allergic Rhinitis, and Others), by Treatment Type (Anti-allergy Drugs and Immunotherapy), by Dosage Form (Tablets, Inhalers, Nasal Sprays, Eye Drops, and Injections), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Ragweed Pollen Allergy Treatment Market, by Drug Class (Antihistamines, Decongestants, Nasal Corticosteroids, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter